Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2025-12-29 @ 1:14 AM
Study NCT ID:
NCT01150903
Status:
COMPLETED
Last Update Posted:
2021-07-19
First Post:
2010-06-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Identification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-05
Start Date Type:
None
Primary Completion Date:
2010-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-08
Completion Date Type:
ACTUAL
First Submit Date:
2010-06-24
First Submit QC Date:
None
Study First Post Date:
2010-06-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-04-03
Results First Submit QC Date:
None
Results First Post Date:
2012-05-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-15
Last Update Post Date:
2021-07-19
Last Update Post Date Type:
ACTUAL